February 10, 2025: MaaT Pharma : Pioneering microbiome-driven therapy as new pillar in oncology – Fierce Pharma

February 20, 2025: Hervé Affagard talks Phase 3 results, the regulatory landscape and industry collaborations – Microbiome Times